Almirall joins FACILITATE, a patient-focused Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants
Almirall brings experience in privacy and pharmaceutical law, as well as in developing guidance, standards and recommendations for communicating clinical trial data to patients The project will last four years and involves 27 partners from 16 EU and extra-EU Member States, including patient organisations, hospitals, universities, SMEs and members of the European Federation of Pharmaceutical …